Valérie Bayard, LL.M.
Associate | Attorney at law
T. +41 58 510 92 93
valerie.bayard@advestra.ch
vCard
LinkedIn
Valérie Bayard advises clients on capital market transactions, as well as on regulatory matters. One of her main areas of practice is assisting banks and issuers in the context of IPOs, capital increases and various securities law matters.
She also advises financial services providers on compliance with their regulatory duties. Furthermore, Valérie assists companies on M&A and financing transactions and advises clients in general corporate and contract law matters.
Capital Markets
- Advising Swiss Prime Site on the placement of convertible loan notes
- Advising Lonza on the Placement of bonds
- Advising Goldman Sachs, Jefferies and ZKB on the rights offering by Meyer Burger
- Advising Xlife Sciences, the first equity issuer on the SIX Swiss Exchange Sparks segment
- Advising Credit Suisse and UBS on the IPO of SKAN
- Advising Morgan Stanley, UBS and Zürcher Kantonalbank on the placement of shares of Bachem Holding
- Advising Bank of America Merrill Lynch, J.P. Morgan, UBS und Société Générale on the placement of shares of Adecco Group
Corporate|M&A
- Advising Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals
- Advising Monte Valle Partners on the acquisition of TradeXBank Ltd.
- Advising SIG Combibloc on the acquisition of Pactiv Evergreen's fresh carton business in Asia
- Associate at Advestra (since 2021)
- Admitted to the Bar of the canton of Zurich (2021)
- Junior associate at a leading Swiss law firm (2018–2020)
- LL.M. at Leiden University (2018)
- Junior Risk Manager for a major Swiss Bank (2017)
- Trainee with the General Counsel of a major Swiss Bank (2016)
- MLaw at University of Zurich (2016)
- BLaw at University of Zurich (2015)
- Zurich Bar Association (ZAV)
- Leiden University Alumni
- Shareholder Activism in Switzerland, in Lexology Getting The Deal Through Swiss 2023 M&A Practice Guide (with Rashid Bahar and Valérie Bayard)
- Shareholder Activism in Switzerland, in Lexology Getting The Deal Through Swiss 2022 M&A Practice Guide (with Rashid Bahar and Annette Weber)
- German
- English
- Italian
- All Swiss Courts
- Advestra advises Goldman Sachs and UBS on the placement of CHF 200m convertible bonds due 2029 and the public repurchase offer for outstanding convertible bonds due 2025 of DocMorris
- Advestra advises on the rights offering by Meyer Burger
- Advestra advises Swiss Prime Site on the placement of bonds
- Advestra advises Kinarus Therapeutics Holding AG and Curatis AG on the Combination of Their Businesses by Way of Reverse Merger
- Advestra advises on the first Swiss De-SPAC
- Advestra advises HSBC, Morgan Stanley, UBS and the other members of the banking syndicate on the rights offering and the high-yield bonds of ams-OSRAM
- Advestra advised the banking syndicate on the placement of EUR 1.5bn bonds of Roche
- Advestra advises Lonza on the placement of bonds
- Advestra advises Will Semiconductor Co., Ltd. Shanghai on its GDR offering and listing on SIX Swiss Exchange
- Advestra advises Salt on its high yield bond offering